Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 29

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 29
---
 |     | developing and recommending to our board of directors criteria for board and committee membership; |

| • |     | establishing procedures for identifying and evaluating board of director candidates, including nominees recommended by shareholders; |

| • |     | evaluating the performance of our board of directors and of individual directors; |

| • |     | reviewing the composition of our board of directors to ensure that it is composed of members containing the appropriate skills and expertise to advise us; |

| • |     | considering and making recommendations to our board of directors regarding the composition of our board of directors and its committees; |

| • |     | identifying individuals qualified to become members of our board of directors; |

| • |     | considering and assessing the independence of the members of our board of directors; |

| • |     | considering questions of possible conflicts of interest of directors as such questions arise; |

| • |     | developing and reviewing with the Chief Executive Officer the succession plans for our executive officers; |

| • |     | reviewing developments in corporate governance practices; |

| • |     | developing and recommending to the board a set of corporate governance policies and principles, including a code of business conduct and ethics; |

19

| • |     | evaluating the adequacy of our corporate governance practices and reporting; |

| • |     | reviewing and overseeing the company’s environmental, social and governance (“ESG”) strategy, initiatives, and policies, including matters related to environmental, health and safety, and ethics and compliance; and |

| • |     | overseeing an annual evaluation of the board’s performance. |

We believe that the composition and functioning of our nominating and corporate governance committee complies with all applicable requirements of the Sarbanes-Oxley Act, and all applicable SEC and Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us. Our nominating and corporate governance committee employs a rigorous, thorough and in-depthprocess to identify director candidates and recommend the strongest possible director nominees to the full board of directors. The nominating and corporate governance committee seeks to assemble a board that, as a whole, possesses the appropriate balance of professional and industry knowledge, financial expertise, public company governance experience and high-level management experience necessary to oversee and direct our business and strategy. The nominating and corporate governance committee believes that candidates for director should have certain minimum qualifications, including the ability to read and understand basic financial statements, understanding our industry and having the highest personal integrity and ethics. The nominating and corporate governance